Amgen’s quarterly profit slid 1% but its revenue jumped 22%, according to its latest earnings report released Thursday afternoon.
For the quarter, Amgen recorded $7.4 billion in revenue, thanks largely to 22% growth in product sales and 25% growth in volume. Amgen’s non-GAAP earnings per share (EPS) fell 1% of $3.96 but still topped Wall Street estimates of $3.89.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,